ASTCT Talks is the official podcast of the American Society for Transplantation and Cellular Therapy (ASTCT). We chat with industry leaders from all areas of the blood and marrow transplantation and cellular therapy field, including doctors, physician assistants, pharmacists, nurses, administrators, social workers, and more. We hope you enjoy listening!
Join ASTCT Director of Government Relations, Molly Ford, and Reimbursement and Policy Advisors from Nimitt Consulting for a webinar on Medicare rule updates on August…
ASTCT introduces the Gene Therapy Summit, an interactive meeting of representatives from academic and clinical centers, the biotechnology industry, ASTCT and additional collaborative professional societies…
We are excited to announce an upcoming virtual roundtable on Wednesday, August 6, at 2 p.m. CDT that will delve into insights and key takeaways…
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals…
ASTCT introduces the Gene Therapy Summit, an interactive meeting of representatives from academic and clinical centers, the biotechnology industry, ASTCT and additional collaborative professional societies…
Montoro J, Eikema D-J, Piepenbroek B, et al. Donor Impact on Allogeneic Transplant Outcomes with PTCy for Severe Aplastic Anemia: A Study of the SAAWP…
ASTCT introduces the Gene Therapy Summit, an interactive meeting of representatives from academic and clinical centers, the biotechnology industry, ASTCT and additional collaborative professional societies…
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals…
Researchers from Stanford University have demonstrated that administering precision-selected donor regulatory T-cell (Treg) therapy significantly improves graft-versus-host disease-free,…
The provided podcast describes the NAVULTRA Registry, an international, multicenter observational study comparing outcomes of two Transcatheter Aortic Valve Replacement (TAVR) devices: the self-expanding Navitor (NAV) and the balloon-expandable SAPIEN 3…
